Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
-2.14 %
$ 212 M
Market Cap
-1.61
P/E
FDMT - PRE-TAX INCOME
Pre-tax Income FDMT - 4D Molecular Therapeutics, Inc.
-101 M
LAST VALUE
-18.91%
2 YEAR CAGR
-60.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR